What is Wedbush’s Estimate for ORKA FY2029 Earnings?
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) – Equities researchers at Wedbush issued their FY2029 EPS estimates for shares of Oruka Therapeutics in a research note issued to investors on Wednesday, May 14th. Wedbush analyst D. Nierengarten forecasts that the company will earn ($4.14) per share for the year. Wedbush currently has a “Outperform” rating […]
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) – Equities researchers at Wedbush issued their FY2029 EPS estimates for shares of Oruka Therapeutics in a research note issued to investors on Wednesday, May 14th. Wedbush analyst D. Nierengarten forecasts that the company will earn ($4.14) per share for the year. Wedbush currently has a “Outperform” rating […]
